Home » KENSEY NASH ANNOUNCES COMPLETION OF CAROTID PILOT TRIAL USING THE TRIACTIV PROGUARD SYSTEM
KENSEY NASH ANNOUNCES COMPLETION OF CAROTID PILOT TRIAL USING THE TRIACTIV PROGUARD SYSTEM
April 26, 2006
Kensey Nash Corporation today announced that it has completed enrollment of a pilot trial for its TriActiv ProGuard Embolic Protection System in carotid stenting procedures. Data from the study will support a CE Mark application for use of the device during carotid stenting procedures. It also will support an IDE submission to the U.S. Food and Drug Administration (FDA) to begin a larger pivotal trial in the U.S. for the same indication. The U.S. pivotal trial is expected to commence during the summer of 2006. PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/04-26-2006/0004347777&EDATE=)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct